Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole Prophylaxis in AML
NCT00152594Phase 3Terminated
- Sponsor
- University of Cologne
- Start
- Oct 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in invasive fungal infection (IFI) comparing Voriconazole with Placebo (2 arms). Primary endpoint: Incidence of lung infiltrates at Day 21. Started Oct 2004; status: terminated.
02
Drugs
voriconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00152594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152594.